Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Chinese Companies Mull New Markets As Home Growth Slows

This article was originally published in PharmAsia News

Executive Summary

At a recent industry conference in Shanghai, experts discussed the recent slowdown in the Chinese pharma sector, while noting that there are still many positive factors for growth in the country. As a pioneer in the U.S. market, Huahai Pharm also shared experiences that might help other Chinese firms expand overseas.


Related Content

GDUFA’s Perfect Storm: Approvals Drop, Submissions Jump


Related Companies




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts